Revolution Medicines (RVMD) Retained Earnings (2019 - 2026)
Revolution Medicines (RVMD) recorded quarterly Retained Earnings of -$622000.0 in Q1 2026, up 99.98% quarter-over-quarter from -$2.9 billion in Q4 2025, and up 99.97% on a YoY basis from -$311048.4 in Q1 2025.
Revolution Medicines (RVMD) Retained Earnings (2019 - 2026) Analysis & Trends
Revolution Medicines' Retained Earnings history runs 8 years deep, the most recent figure standing at -$622000.0 for Q1 2026.
- In Q1 2026, Retained Earnings rose 99.97% year-over-year to -$622000.0; the TTM figure through Mar 2026 stood at -$622000.0 (up 99.97% YoY), while the FY2025 annual figure was -$2.9 billion, down 65.1% from the prior year.
- Retained Earnings was -$622000.0 for Q1 2026 at Revolution Medicines, up from -$2.9 billion in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $3.8 million in Q3 2024 to a low of -$2.9 billion in Q4 2025.
- Historically, Retained Earnings has averaged -$1.1 billion across 5 years, with a median of -$867.7 million in 2023.
- The sharpest annual moves came in 2022 and 2024: Retained Earnings slumped 6350100.0% in 2022, then surged 537.66% in 2024.
- A 5-year view of Retained Earnings shows it stood at -$701.3 million in 2022, then plunged by 62.22% to -$1.1 billion in 2023, then tumbled by 52.75% to -$1.7 billion in 2024, then sank by 65.1% to -$2.9 billion in 2025, then jumped by 99.98% to -$622000.0 in 2026.
- The last three Retained Earnings figures came in at -$622000.0 (Q1 2026), -$2.9 billion (Q4 2025), and -$2.5 billion (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Revolution Medicines | 32.33 Bn | 32.33 Bn | - | -622,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -622,000.00 |
| Dec 31, 2025 | -2.87 Bn |
| Sep 30, 2025 | -2.50 Bn |
| Jun 30, 2025 | -2.20 Bn |
| Mar 31, 2025 | -2.00 Bn |
| Dec 31, 2024 | -1.74 Bn |
| Sep 30, 2024 | 3.81 Mn |
| Jun 30, 2024 | -1.39 Bn |
| Mar 31, 2024 | -1.25 Bn |
| Dec 31, 2023 | -1.14 Bn |
| Sep 30, 2023 | -871,000.00 |
| Jun 30, 2023 | -867.70 Mn |
| Mar 31, 2023 | -769.44 Mn |
| Dec 31, 2022 | -701.34 Mn |
| Sep 30, 2022 | -644.83 Mn |
| Jun 30, 2022 | -571.50 Mn |
| Mar 31, 2022 | -510.30 Mn |
| Dec 31, 2021 | -452.64 Mn |
| Sep 30, 2021 | -40,000.00 |
| Jun 30, 2021 | 9,000.00 |